Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Metrics to compare | OIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOILPeersSector | |
---|---|---|---|---|
P/E Ratio | −22.1x | −3.6x | −0.7x | |
PEG Ratio | 3.75 | −0.13 | 0.00 | |
Price/Book | 9.6x | 2.7x | 2.6x | |
Price / LTM Sales | 44.8x | 2.6x | 3.2x | |
Upside (Analyst Target) | - | 162.6% | 43.2% | |
Fair Value Upside | Unlock | 5.2% | 6.8% | Unlock |